Boardroom Alpha
Research library
SPACs · Oct 23, 2026

SPAC Market Update October 23, 2026: CHAR Extension Clears After $63M Redemptions

Charlton Aria Acquisition Corp (CHAR) won approval for its extension vote on October 23, 2026, with $63M removed from trust and 5,725,962 shares redeemed. The vote pushed CHAR’s deadline to October 25, 2027 as it pursues KQC Quantum Inc.

SPAC IPO Update — October 23, 2026

No SPAC IPOs priced on October 23, 2026; October MTD now stands at 4 IPOs totaling $491M over 23 sessions.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 4•Prior: 5•MoM: -1
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
19
Jun ’26
18
Jul ’26
12
Aug ’26
5
Sep ’26
4
Oct ’26
Source: Boardroom Alpha
IPO Activity SnapshotMonth-to-date: 4 IPOs ($491M) vs. first 23 days of last month 4 ($768M) · 12-mo avg: 16/mo
$ totals include underwriter over-allotment.
New SPAC IPOs
Date Ticker Issuer IPO Size Trust Funding
Oct 16 TCXB TCGX ACQUISITION CORP II $100M 100.0%
Oct 14 FLSC FRAZIER LIFE SCIENCES ACQUISITION CORP II $75M 100.0%
Source: Boardroom Alpha

Daily SPAC Update — October 23, 2026

SPAC VOTE RESULTS
CHARLTON ARIA ACQUISITION CORP (CHAR) * Extend to October 25, 20275,725,962 redeemed · $63,157,361 removed · trust $11.03

EXTENSION VOTES
OAKTREE ACQUISITION CORP III LIFE SCIENCES (OACC)vote October 23, 2026 -> extend from October 25, 2026 to May 25, 2027

SPAC EXTENSIONS
UY SCUTI ACQUISITION CORP (UYSC) * Extension FilingUYSC extends business combination deadline via promissory notes to Isdera HK and Xinghui; Joinder/First Amendment add Isdera entities to the Merger Agreement.
DT CLOUD STAR ACQUISITION CORP (DTSQ) * Extension FilingDT Cloud Star SPAC extends its initial business combination deadline to November 26, 2026 via a cash extension deposit.
CHARLTON ARIA ACQUISITION CORP (CHAR) * Extension FilingShareholders approve up to 12 one-month extensions to complete a business combination, funded by sponsor deposits.

SEPARATE WARRANTS/RIGHTS
October 23: PINE TREE ACQUISITION CORP (PAXG)

OTHER SPAC NEWS
GRAF GLOBAL CORP (TONT) * Investor Deck
INFLECTION POINT ACQUISITION CORP VI (IPFX) * Merger Agreement AmendmentAmendment to move listing to NYSE and adjust PubCo board size, subject to Quantum Space approval.
K&F GROWTH ACQUISITION CORP II (KFII) * Investor Deck
K&F GROWTH ACQUISITION CORP II (KFII) * Non-Binding LOIK&F Growth Acquisition II and Pearl’s David’s Bridal announce amended LOI for potential business combination.
NEWBURY STREET II ACQUISITION CORP (NTWO) * Merger Agreement
SPARK I ACQUISITION CORP (SPKLF) * Media TranscriptZincFive outlines AI dynamic power roadmap and U.S. manufacturing plan amid SPAC timing. Backlog growth noted.
STARRY SEA ACQUISITION CORP (SSEA) * Redemption Update * 3,896,270 redeemedAmendment corrects the redemption tender count to 3,896,270 shares; monthly extension fee is $60,000 per one-month extension following the Oct 19 Extension Meeting.

SPAC LISTING RULE NOTICES
ARC GROUP ACQUISITION I CORP (ARCL) * Listing Rule NoticeNasdaq extends ARC Group’s warrant compliance deadline to Feb 23, 2027. The company plans to regain compliance before the deadline.
GLOBA TERRA ACQUISITION CORP (GTERA) * Listing Rule NoticeNasdaq may delist Globa Terra for failing to complete a business combination; company will appeal and seek a date extension.

SPAC DEALS ANNOUNCED
October 21 | Apex Tech Acquisition Inc (TRAD) + Korai Flix IncKorai Flix Inc is an interactive online entertainment platform headquartered in South Korea. It offers AI-powered interactive content experiences, including AI short dramas and AI companion avatars. The platform serves a growing user base across Asia, providing personalized and immersive entertainment experiences.
October 19 | Tcgx Acquisition Corp (TCGX) + TriGemX BioTriGemX Bio is a biotechnology company developing elismetrep, a potential first-in-class TRPM8 channel blocker aimed at treating migraines. The company’s research focuses on neural signaling pathways, particularly targeting the trigeminal ganglion, where TRPM8 is expressed. Elismetrep is currently undergoing Phase 3 trials for acute migraine treatment, with initial results expected in mid-2027.

SPAC Executive & Director Moves — October 23, 2026

SPAC Executive & Director Moves
Company Ticker Moves
TAVIA ACQUISITION CORP TAVI
  • Kanat Mynzhanov resigned from Tavia Acquisition Corp.’s Board on October 16, 2026. Kenneth J. Anderson was appointed effective October 17, 2026 as a Class III director and joined the Audit and Compensation Committees; no compensation terms were disclosed.  (view source)
Source: SEC EDGAR filings via Boardroom Alpha

SPAC Movers — October 23, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
FUTURE VISION II ACQUISITION CORP FVN 6.0% $ 11.98 Announced
RISING DRAGON ACQUISITION CORP RDAC 4.2% $ 5.00 Announced
MELAR ACQUISITION CORP I MACI 3.3% $ 11.37 Announced
QUETTA ACQUISITION CORP QETA 3.1% $ 11.55 Announced
SILVERBOX CORP IV SBXD 2.6% $ 11.39 Announced
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
BLACK HAWK ACQUISITION CORP BKHA -12.4% $ 4.29 Announced
RIBBON ACQUISITION CORP RIBB -7.4% $ 6.11 Announced
RF ACQUISITION CORP II RFAI -3.8% $ 34.50 Announced
CALISA ACQUISITION CORP ALIS -1.9% $ 8.19 Announced
JATT II ACQUISITION CORP TBD -1.4% $ 10.30 Announced
Source: Boardroom Alpha market data

Frequently Asked Questions

  • How much did CHAR investors redeem at the extension vote?
    Charlton Aria Acquisition Corp (CHAR) investors redeemed 5,725,962 shares at $11.03 per share, removing $63M from trust in the October 23, 2026 extension vote.
  • What deadline did Charlton Aria Acquisition Corp approve?
    Charlton Aria Acquisition Corp (CHAR) extended its business-combination deadline to October 25, 2027 after shareholders approved the extension.
  • How many SPAC IPOs priced in October 2026 through October 23?
    4 SPAC IPOs priced for $491M, including over-allotment, through October 23, 2026, versus 4 IPOs for $768M over the same September period.
  • Which other SPAC extension actions appeared today?
    UY Scuti Acquisition Corp (UYSC) extended via promissory notes to Isdera HK and Xinghui; DT Cloud Star Acquisition Corp (DTSQ) extended via a cash extension deposit.
  • What deal-related filings did KFII and IPFX make today?
    K&F Growth Acquisition Corp II (KFII) disclosed an amended non-binding LOI with Pearl’s David’s Bridal. Inflection Point Acquisition Corp VI (IPFX) amended its merger agreement to move the listing to NYSE and adjust PubCo board size, subject to Quantum Space approval.


Get it in your inbox

The Daily SPAC Update in your inbox

Every IPO, vote, and DeSPAC close — analyzed daily for finance professionals.

ShareXLinkedIn

Published Oct 23, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer